Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
Aim. This study compared the effects of telmisartan and losartan on nonalcoholic fatty liver disease (NAFLD) and biochemical markers of insulin resistance in hypertensive NAFLD patients with type 2 diabetes mellitus. Methods. This was a randomized, open-label, parallel-group comparison of therapy wi...
Main Authors: | Takumi Hirata, Kengo Tomita, Toshihide Kawai, Hirokazu Yokoyama, Akira Shimada, Masahiro Kikuchi, Hiroshi Hirose, Hirotoshi Ebinuma, Junichiro Irie, Keisuke Ojiro, Yoichi Oikawa, Hidetsugu Saito, Hiroshi Itoh, Toshifumi Hibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2013/587140 |
Similar Items
-
Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
by: Takumi Hirata, et al.
Published: (2014-01-01) -
The Effects of Telmisartan and Losartan on Insulin Sensitivity
by: Okan Bakıner, et al.
Published: (2013-12-01) -
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
by: Fini Massimo, et al.
Published: (2005-05-01) -
I . Synthesis and application of catalytic for Hetero Diels-Alder reaction II. Synthesis of Losartan and Telmisartan analogous
by: ZH-XIANG XIAO, et al.
Published: (2017) -
Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension
by: Berna İ Aydoğan, et al.
Published: (2019-07-01)